Michaela Despins, ATC, LAT Preventive Medicine - Sports Medicine Medicare: Not Enrolled in Medicare Practice Location: 30 Belgrade Ave Ste A, Auburn, ME 04210 Phone: 207-783-0018 Fax: 207-783-0019 |
News Archive
Privately held SynCardia Systems, Inc. announced today that it had raised $14 million to fund the rapid growth of the only approved medical device that eliminates the symptoms and source of end-stage heart failure, the SynCardia temporary Total Artificial Heart. The SynCardia Total Artificial Heart is the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart.
Researchers have successfully developed two biomarkers that could help predict the risk of a heart condition and stroke.
Tennessee-based Community Health Systems, which runs 206 hospitals in 29 states, says no medical information was exposed, however.
Researchers at Children's Hospital of Pittsburgh of UPMC and University of Pittsburgh School of Medicine have developed and refined a blood test that could help clinicians identify infants who may have had bleeding of the brain as a result of abusive head trauma, sometimes referred to as shaken baby syndrome.
Data presented today at the American College of Allergy, Asthma & Immunology (ACAAI) show that Xolair (Omalizumab) for Subcutaneous Use significantly reduced asthma attacks in children aged six through 11 with moderate or severe persistent allergic asthma inadequately controlled with inhaled corticosteroids.
› Verified 4 days ago